SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, ...
On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) for lecanemab-irmb (Leqembi) subcutaneous autoinjector (SC-AI) for weekly ...
If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds Would potentially provide a cost-effective and ...
Please provide your email address to receive an email when new articles are posted on . A patient should be supine or sitting when an epinephrine autoinjector device is administered per best practice ...
TOKYO/CAMBRIDGE - The U.S. Food and Drug Administration has accepted Eisai Co., Ltd.’s application for a weekly subcutaneous autoinjector version of its Alzheimer’s treatment lecanemab-irmb (LEQEMBI), ...
TOKYO/CAMBRIDGE - The U.S. Food and Drug Administration has accepted Eisai’s application for a subcutaneous autoinjector version of its Alzheimer’s treatment lecanemab-irmb (LEQEMBI) under priority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results